Indication
Cholangitis
5 clinical trials
8 products
1 drug
Clinical trial
Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy in Biliary Atresia: a Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Combination Use of Intravenous Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography ; A Randomized Control TrialStatus: Recruiting, Estimated PCD: 2024-06-30
Drug
KetamineProduct
MidazolamProduct
PethidinClinical trial
A Phase 2 Open Label, Proof of Concept Study of HTD1801 (BUDCA) in Adult Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to Standard Therapy - PRONTO-PBCStatus: Completed, Estimated PCD: 2022-05-31
Product
HTD1801Clinical trial
Very Short-course Versus Standard Course Antibiotic Therapy in Patients With Acute ChOlangitis After Adequate Endoscopic BiliaRy drAinageStatus: Recruiting, Estimated PCD: 2026-03-01
Product
CeftriaxoneClinical trial
Randomized Trial of Short Antibiotic Course to Decrease Post ERCP CholangitisStatus: Recruiting, Estimated PCD: 2024-02-23
Product
Levofloxacin